机械通气肺炎患者强化抗菌药物降阶梯治疗:一项交叉研究
本研究为前瞻性交叉试验,在Barnes-Jewish医院两个内科ICU(共34床)比较常规抗菌药物管理(RAM)与强化抗菌药物降阶梯(EAD)。EAD组由重症 fellow、ICU主治医师和ICU药师组成专职团队每日审查抗生素医嘱和微生物结果。共283例疑似肺炎需机械通气的患者可评估,RAM组139例(49.1%),EAD组144例(50.9%)。早期治疗失败率分别为23.7%和27.8%(P=0.438),降阶梯率分别为66.0%和67.3%(P=0.845),总抗生素天数中位数均为7.0天(P=0.616),医院死亡率25.2% vs 35.4%(P=0.061),住院时间12.0天 vs 11.0天(P=0.918)。结论:在已高水平管理抗菌药物的学术ICU,增加EAD项目未带来更大降阶梯或缩短总抗生素疗程。
要点
- 在已实行高水平抗菌药物管理的学术ICU,增加EAD团队未提高降阶梯率:RAM组66.0% vs EAD组67.3%(P=0.845)。
- EAD未缩短总抗生素天数:RAM组中位7.0天(4.0, 9.0) vs EAD组7.0天(4.0, 8.8)(P=0.616)。
- EAD未降低早期治疗失败率:RAM组23.7% vs EAD组27.8%(P=0.438)。
- EAD未显著降低医院死亡率:RAM组25.2% vs EAD组35.4%(P=0.061)。
- EAD未缩短住院时间:RAM组中位12.0天(6.0, 20.0) vs EAD组11.0天(6.0, 22.0)(P=0.918)。
适用人群与场景
- 在学术转诊中心Barnes-Jewish医院的两个内科ICU(共34床)中,疑似肺炎且需要机械通气的成人患者。
- 共283例可评估患者,RAM组139例(49.1%),EAD组144例(50.9%)。
处置流程与药物剂量
- EAD组由专职团队(第二年重症监护fellow、ICU主治医师和ICU药师)每日审查抗生素医嘱和微生物学结果。
- 根据微生物学检测结果和临床治疗反应,在适当时机提出抗菌药物降阶梯建议。
- 对照组接受常规抗菌药物管理(RAM)。
研究设计与关键结果
- 研究类型:前瞻性交叉试验,在Barnes-Jewish医院两个内科ICU(共34床)进行,比较常规抗菌药物管理(RAM)与强化抗菌药物降阶梯(EAD)。
- 共283例疑似肺炎需机械通气的患者可评估:RAM组139例(49.1%),EAD组144例(50.9%)。
- 早期治疗失败(基于临床恶化)在RAM组33例(23.7%) vs EAD组40例(27.8%)(P=0.438)。
- 在剩余患者中,抗菌药物降阶梯在RAM组70例(66.0%) vs EAD组70例(67.3%)(P=0.845)。
- 总抗生素天数中位数(四分位距):RAM组7.0天(4.0, 9.0) vs EAD组7.0天(4.0, 8.8)(P=0.616)。
- 医院死亡率:RAM组25.2% vs EAD组35.4%(P=0.061)。
- 住院时间中位数(四分位距):RAM组12.0天(6.0, 20.0) vs EAD组11.0天(6.0, 22.0)(P=0.918)。
证据类型、等级与局限
- 证据类型:前瞻性交叉试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在已实行高强度日间人员配置模式且抗菌药物管理已达高水平的学术ICU中,增加EAD项目与更高降阶梯率或缩短总抗生素疗程无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Antibiotics are commonly administered to hospitalized patients with infiltrates for possible bacterial pneumonia, often leading to unnecessary treatment and increasing the risk for resistance emergence. Therefore, we performed a study to determine if an enhanced antibiotic de-escalation practice could improve antibiotic utilization in mechanically ventilated patients with suspected pneumonia cared for in an academic closed intensive care unit (ICU).
METHODS: This was a prospective cross-over trial comparing routine antibiotic management (RAM) and enhanced antimicrobial de-escalation (EAD) performed within two medical ICUs (total 34 beds) at Barnes-Jewish Hospital, an academic referral center. Patients in the EAD group had their antibiotic orders and microbiology results reviewed daily by a dedicated team comprised of a second-year critical care fellow, an ICU attending physician and an ICU pharmacist. Antibiotic de-escalation recommendations were made when appropriate based on microbiologic test results and clinical response to therapy.
RESULTS: There were 283 patients evaluable, with suspected pneumonia requiring mechanical ventilation: 139 (49.1%) patients in the RAM group and 144 (50.9%) in the EAD group. Early treatment failure based on clinical deterioration occurred in 33 (23.7%) and 40 (27.8%) patients, respectively (P = 0.438). In the remaining patients, antimicrobial de-escalation occurred in 70 (66.0%) and 70 (67.3%), respectively (P = 0.845). There was no difference between groups in total antibiotic days ((median (interquartile range)) 7.0 days (4.0, 9.0) versus 7.0 days (4.0, 8.8) (P = 0.616)); hospital mortality (25.2% versus 35.4% (P = 0.061)); or hospital duration (12.0 days (6.0, 20.0) versus 11.0 days (6.0, 22.0) (P = 0.918).
CONCLUSIONS: The addition of an EAD program to a high-intensity daytime staffing model already practicing a high-level of antibiotic stewardship in an academic ICU was not associated with greater antibiotic de-escalation or a reduction in the overall duration of antibiotic therapy.
TRIAL REGISTRATION: ClinicalTrials.gov, NCT02685930 . Registered on 26 January 2016.
参考来源
- Trupka T, Fisher K, Micek ST, et al. Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study. Crit Care. 2017. PMID: 28709439. doi:10.1186/s13054-017-1772-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。